Suppr超能文献

急性冠状动脉综合征后1年内及以后全因死亡率和缺血性事件的预测因素:EPICOR注册研究结果

Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.

作者信息

Rossello Xavier, Bueno Héctor, Pocock Stuart J, Van de Werf Frans, Danchin Nicolas, Annemans Lieven, Medina Jesús, Zeymer Uwe

机构信息

Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Clin Cardiol. 2019 Jan;42(1):111-119. doi: 10.1002/clc.23116. Epub 2018 Dec 7.

Abstract

BACKGROUND

Patients discharged after an acute coronary syndrome (ACS) have substantial risk of recurrent ischemic events or dying.

HYPOTHESIS

A difference may exist in risk predictors for all-cause mortality and ischemic events between year 1 and 2 of follow-up post-ACS.

METHODS

EPICOR (NCT01171404) was a prospective, international, real-world cohort study of consecutive patients hospitalized for ACS within 24 hours of symptom onset and surviving to discharge. Total of 10 568 patients were enrolled (555 hospitals; 20 countries) and followed-up for 2 years. From these, 4943 were admitted with ST-elevation myocardial infarction (STEMI) and 5625 with non-ST-elevation ACS (NSTE-ACS). Potential baseline predictors of major adverse cardiac and cerebrovascular events (MACCE; death, non-fatal myocardial infarction [MI], non-fatal stroke) were evaluated in year 1 and 2 post-discharge.

RESULTS

MACCE incidence per 100 person-years at risk within and after 1 year was 5.3 vs 3.6, primarily death (4.1 vs 2.3), with no significant differences for MI or stroke. Older age, lack of coronary revascularization, raised creatinine, low hemoglobin, previous cardiac disease, previous chronic obstructive pulmonary disease, raised glucose, male sex, and geographic region were risk factors for MACCE in both year 1 and 2. By contrast, low ejection fraction, poorer quality of life, low body mass index (BMI) <20 kg/m , in-hospital cardiac complications, and Killip class lost predictive power after 1 year.

CONCLUSION

We observed continuous MACCE risk during 2 years of follow-up after discharge for ACS, with greater mortality within the first year. Specific predictors at discharge for events after 1 year could not be identified.

摘要

背景

急性冠状动脉综合征(ACS)后出院的患者有发生复发性缺血事件或死亡的重大风险。

假设

ACS后随访第1年和第2年全因死亡率和缺血事件的风险预测因素可能存在差异。

方法

EPICOR(NCT01171404)是一项前瞻性、国际性、真实世界队列研究,纳入症状发作24小时内住院且存活至出院的连续性ACS患者。共纳入10568例患者(555家医院;20个国家),并随访2年。其中,4943例为ST段抬高型心肌梗死(STEMI)患者,5625例为非ST段抬高型ACS(NSTE-ACS)患者。在出院后第1年和第2年评估主要不良心脑血管事件(MACCE;死亡、非致死性心肌梗死[MI]、非致死性卒中)的潜在基线预测因素。

结果

1年内及1年后每100人年的MACCE发生率分别为5.3和3.6,主要为死亡(4.1和2.3),MI或卒中无显著差异。年龄较大、未进行冠状动脉血运重建、肌酐升高、血红蛋白降低、既往有心脏病、既往有慢性阻塞性肺疾病、血糖升高、男性以及地理区域是第1年和第2年MACCE的危险因素。相比之下,射血分数降低、生活质量较差、低体重指数(BMI)<20 kg/m²、院内心脏并发症以及Killip分级在1年后失去预测能力。

结论

我们观察到ACS出院后2年随访期间持续存在MACCE风险,第1年死亡率更高。无法确定出院时1年后事件的特定预测因素。

相似文献

2
Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.
Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):727-737. doi: 10.1177/2048872617719638. Epub 2017 Aug 4.
6
Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.
Curr Vasc Pharmacol. 2020;18(1):92-99. doi: 10.2174/1570161117666181227122355.
7
Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome.
Clin Res Cardiol. 2018 Sep;107(9):836-844. doi: 10.1007/s00392-018-1254-y. Epub 2018 Apr 16.
9
[Age-related differences in the management and outcome of acute coronary syndrome under the chest pain center model: a multicenter retrospective study].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):318-323. doi: 10.3760/cma.j.cn121430-20200806-00565.
10
Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: findings from the EPICOR study.
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):254-62. doi: 10.1177/2048872614551544. Epub 2014 Sep 10.

引用本文的文献

3
Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis.
Front Cardiovasc Med. 2024 Dec 10;11:1334730. doi: 10.3389/fcvm.2024.1334730. eCollection 2024.
6
Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction.
Postepy Kardiol Interwencyjnej. 2023 Mar;19(1):31-39. doi: 10.5114/aic.2022.123884. Epub 2023 Jan 23.
7
Characteristics of Wellens' Syndrome in the Current PCI Era: A Single-Center Retrospective Study.
Emerg Med Int. 2023 Mar 24;2023:8865553. doi: 10.1155/2023/8865553. eCollection 2023.
8
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines.
Eur Heart J Qual Care Clin Outcomes. 2023 Dec 22;9(8):796-805. doi: 10.1093/ehjqcco/qcad007.

本文引用的文献

1
Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome.
Clin Res Cardiol. 2018 Sep;107(9):836-844. doi: 10.1007/s00392-018-1254-y. Epub 2018 Apr 16.
4
Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score.
Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):727-737. doi: 10.1177/2048872617719638. Epub 2017 Aug 4.
5
Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
Int J Cardiol. 2017 Oct 15;245:27-34. doi: 10.1016/j.ijcard.2017.07.039. Epub 2017 Jul 15.
7
Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association.
Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):34-59. doi: 10.1177/2048872616643053. Epub 2016 Sep 20.
8
Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care.
J Am Coll Cardiol. 2015 Sep 15;66(11):1273-1285. doi: 10.1016/j.jacc.2015.07.018.
9
Long-term use of ticagrelor in patients with prior myocardial infarction.
N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验